High-impact MEN1 mutation carriers were more likely to develop GEP-NETs than patients with low-impact mutations, resulting in a geno-phenotype correlation, which is of importance regarding the genetic counseling and the prognosis of MEN1 syndrome. The gene discussed is MEN1; the disease is multiple endocrine neoplasia type 1.